- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02330133
Mid-life Women: Preventing Unintended Pregnancy and STIs (FemRepro_2)
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
The primary aim of this project was to create and evaluate a theoretically-based, interactive multimedia program for women aged 35-55 to assist them in avoiding unintended pregnancy and sexually transmitted infections (STIs). The intervention, titled "Women's Reproductive Health: A guide to staying healthy," addressed these concerns across the life span and was designed to increase knowledge about (a) pregnancy risk; (b) STI risk; (c) strategies to prevent STIs and unintended pregnancy; (d) influences of sexual partners on risk reduction decisions and behaviors; (e) partner communication techniques; and (f) health care provider communication techniques.Overall features of the program include video, interactive tools, animations, text information pages, and various links both across and within specific modules to link related information. A feature titled "My Notes" allowed the user to save content from the program into an easily retrievable repository.
Motivational videos featuring friendly mid-life hosts could be viewed on the first page of each module, as well as on the home page and topic introduction pages. These videos not only provided specific information about the content, they also provided message framing and set the tone of the program segment. Other videos included testimonials on topics such as contraceptive methods, sexually transmitted infections, and other health information. Interactive materials include an assessment checklist for STI risk, a quiz to help the user identify the types of birth control methods that best fit her lifestyle and preferences, as well as several checklists
Study Type
Enrollment (Actual)
Phase
- Phase 2
Contacts and Locations
Study Locations
-
-
Oregon
-
Eugene, Oregon, United States, 97401
- Oregon Center for Applied Science
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Women aged 25-55.
Exclusion Criteria:
- Males
- Women under 25 years of age and over 55
Study Plan
How is the study designed?
Design Details
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Women's Reproductive Health
Targeted text and video information on website for women aged 25-55 to avoid unplanned pregnancy and sexually transmitted infections
|
Targeted text and video information on website for women aged 25-55 to avoid unplanned pregnancy and sexually transmitted infections
Other Names:
|
|
Active Comparator: Online sexual health content
Online general text-based information about reproductive health issues and STD prevention strategies
|
Online general text-based information about reproductive health issues and strategies for preventing sexually transmitted infections
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Knowledge of reproductive health issues
Time Frame: 7-day posttest and 30-day follow-up
|
A 22-item knowledge scale was created to assess content areas of the program (e.g., 3 items on anatomy & physiology, 16 items on pregnancy prevention, and 4 items on STI prevention).
For example, users were asked to answer the question "A women is most likely to become pregnant (no matter how long or short her menstrual cycle) if she has sexual intercourse about:" with choices being (a) 1 week before menstruation beings, (b) 2 weeks after menstruation begins, (c) 2 weeks before menstruation begins, (d) 1 week after menstruation begins, or (e) do not know.
|
7-day posttest and 30-day follow-up
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Attitudes about reproductive health and prevention
Time Frame: 7-day posttest and 30-day follow-up
|
Participant attitudes were measured using scales that assessed the perceived importance of using a contraceptive method to prevent pregnancy (6 items), the perceived importance of talking with your partner about contraception (4 items) and two additional items measuring the perceived importance of using a contraceptive method to prevent STIs (1 item), and the perceived importance of talking with your healthcare provider (1 item) (alpha =.74, test- retest reliability=.73).
|
7-day posttest and 30-day follow-up
|
|
Self-efficacy for engaging in strategies to prevent pregnancy and communicate with partner about health risks
Time Frame: 7-day posttest and 30-day follow-up
|
Participant self-efficacy was measured using scales that assessed confidence in preventing pregnancy (6 items), and talking with the partner (2 items) (alpha=84, test-retest reliability=.68).
|
7-day posttest and 30-day follow-up
|
|
Intentions to engage in strategies to prevent pregnancy and communicate with
Time Frame: 7-day posttest and 30-day follow-up
|
Participant behavioral intentions were measured using scales that assessed intention of using a contraceptive method (2 items), preventing an STI (4 items), and talking with a sexual partner (4 items) (alpha=.74,
test-retest reliability=.69).
|
7-day posttest and 30-day follow-up
|
Collaborators and Investigators
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- SBIR64R-2
- R44HD044374 (U.S. NIH Grant/Contract)
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Reproductive Health
-
VA Office of Research and DevelopmentUniversity of California, San Francisco; Kaiser PermanenteCompletedContraception | Contraception Behavior | Reproductive Health | Prepregnancy HealthUnited States
-
Boston Children's HospitalGLMA: Health Professionals Advancing LGBTQ+ EqualityCompletedReproductive HealthUnited States
-
Harvard UniversityWeiss Family Program Fund for Research in Development Economics; Harvard Lab...Completed
-
University of California, San FranciscoPopulation Services InternationalCompletedMaternal Health | Delivery | Reproductive HealthIndia
-
Ebru Cirban EkremEge UniversityNot yet recruitingReproductive HealthTurkey
-
Ege UniversityCompletedReproductive HealthTurkey
-
University of California, San FranciscoPublic Health Foundation of IndiaCompletedReproductive Health
-
University of California, San FranciscoInnovations for Poverty Action; Marie Stopes InternationalCompletedReproductive HealthKenya
-
University of California, Los AngelesCompleted
-
Istanbul University - Cerrahpasa (IUC)CompletedHealth Risk Behaviors | Reproductive Health | Sexual HealthTurkey
Clinical Trials on Women's Reproductive Health
-
Centers for Disease Control and PreventionCompleted
-
Swansea UniversityEnrolling by invitationPelvic-floor DisordersUnited Kingdom
-
Wayne State UniversityBlue Cross Blue Shield of Michigan FoundationCompleted
-
Washington University School of MedicineNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); University... and other collaboratorsCompletedObesity | Weight Gain | Women's HealthUnited States
-
RTI InternationalMedical Research Council, South AfricaCompletedHuman Immunodeficiency Virus (HIV) | Condomless Sex | Alcohol and Drug Use | Sexually Transmitted Infections (STIs) | Violence and Victimization | Access and Linkage to Healthcare | Education AdvancementSouth Africa
-
National University Hospital, SingaporeNational University of SingaporeUnknownCardiovascular DiseaseSingapore
-
Innowage LimitedAarogyam UK; Zep FoundationCompletedMenopause | Psychological Stress | Menopause Related ConditionsIndia
-
Eunice Kennedy Shriver National Institute of Child...Medical Research Council, South AfricaCompletedHIV | Substance Abuse | ViolenceSouth Africa